These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16643452)

  • 1. Pulmonary hypertension in thalassaemia major patients with normal left ventricular systolic function.
    Hagar RW; Morris CR; Vichinsky EP
    Br J Haematol; 2006 May; 133(4):433-5. PubMed ID: 16643452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tricuspid regurgitation in patients with beta-thalassemia major.
    Wu KH; Chang JS; Su BH; Peng CT
    Ann Hematol; 2004 Dec; 83(12):779-83. PubMed ID: 15449031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac disease in beta-thalassaemia major: Is it reversible?
    Atiq M; Bana M; Ahmed US; Bano S; Yousuf M; Fadoo Z; Khurshid M
    Singapore Med J; 2006 Aug; 47(8):693-6. PubMed ID: 16865210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of QT dispersion in beta thalassaemia major patients.
    Ulger Z; Aydinok Y; Levent E; Gurses D; Ozyurek AR
    Am J Hematol; 2006 Dec; 81(12):901-6. PubMed ID: 16924653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pulmonary hypertension in patient with beta-thalassemia major].
    Mérault JM; Escamilla R; Degano B; Guittard J; Hermant C; Krempf M
    Rev Mal Respir; 2000 Jun; 17(3):689-91. PubMed ID: 10951965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac status in well-treated patients with thalassemia major.
    Aessopos A; Farmakis D; Hatziliami A; Fragodimitri C; Karabatsos F; Joussef J; Mitilineou E; Diamanti-Kandaraki E; Meletis J; Karagiorga M
    Eur J Haematol; 2004 Nov; 73(5):359-66. PubMed ID: 15458515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High nontransferrin bound iron levels and heart disease in thalassemia major.
    Piga A; Longo F; Duca L; Roggero S; Vinciguerra T; Calabrese R; Hershko C; Cappellini MD
    Am J Hematol; 2009 Jan; 84(1):29-33. PubMed ID: 19006228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relation between left ventricular diastolic indices and serum ferritin in thalassemia major.
    Ashena Z; Ghafurian S; Ehsani MA
    Pediatr Hematol Oncol; 2007; 24(1):3-14. PubMed ID: 17130109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hb E beta +-thalassaemia in west Malaysia: clinical features in the most common beta-thalassaemia mutation of the Malays [IVS 1-5 (G-->C)].
    George E; Wong HB
    Singapore Med J; 1993 Dec; 34(6):500-3. PubMed ID: 8153710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hypertension in beta-thalassemia major and the role of L-carnitine therapy.
    El-Beshlawy A; Youssry I; El-Saidi S; El Accaoui R; Mansi Y; Makhlouf A; Taher A
    Pediatr Hematol Oncol; 2008 Dec; 25(8):734-43. PubMed ID: 19065439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extramedullary Hematopoiesis in β-Thalassemia.
    Kalchiem-Dekel O; Greenbaum U
    Mayo Clin Proc; 2015 Nov; 90(11):1591-2. PubMed ID: 26541258
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulmonary hypertension in beta-thalassemia.
    Aessopos A; Farmakis D
    Ann N Y Acad Sci; 2005; 1054():342-9. PubMed ID: 16339682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure in beta-thalassemia syndromes: a decade of progress.
    Hahalis G; Alexopoulos D; Kremastinos DT; Zoumbos NC
    Am J Med; 2005 Sep; 118(9):957-67. PubMed ID: 16164878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state.
    Singer ST; Kuypers FA; Styles L; Vichinsky EP; Foote D; Rosenfeld H
    Am J Hematol; 2006 Sep; 81(9):670-5. PubMed ID: 16795058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of splenomegaly and splenectomy in beta-thalassemia.
    Aessopos A; Farmakis D; Deftereos S; Tsironi M; Polonifi A; Moyssakis I; Diamanti-Kandaraki E; Papalambros E
    Ann Hematol; 2005 Jun; 84(6):353-7. PubMed ID: 15711802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of pulmonary hypertension in patients with Beta-thalassemia major and normal ventricular function.
    Vlahos AP; Koutsouka FP; Papamichael ND; Makis A; Baltogiannis GG; Athanasiou E; Chaliasos N; Bourantas KL; Kolettis TM
    Acta Haematol; 2012; 128(2):124-9. PubMed ID: 22846514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restrictive pulmonary dysfunction and its predictors in young patients with β-thalassaemia major.
    Bourli E; Dimitriadou M; Economou M; Vlachaki E; Christoforidis A; Maratou E; Stanopoulos I; Argyropoulou P; Aivazis V
    Pediatr Pulmonol; 2012 Aug; 47(8):801-7. PubMed ID: 22328228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose tolerance and beta-cell secretion in patients with thalassaemia major.
    Mangiagli A; Italia S; Campisi S
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():985-6. PubMed ID: 10091179
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantification of siderophages in bronchoalveolar fluid in transfusional and primary pulmonary hemosiderosis.
    Priftis KN; Anthracopoulos MB; Tsakanika C; Tapaki G; Ladis V; Bush A; Nicolaidou P
    Pediatr Pulmonol; 2006 Oct; 41(10):972-7. PubMed ID: 16871595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension in β thalassaemia.
    Anthi A; Orfanos SE; Armaganidis A
    Lancet Respir Med; 2013 Aug; 1(6):488-96. PubMed ID: 24429247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.